Bryan Zimdahl
Eureka Therapeutics (United States)(US)
Publications by Year
Research Areas
CAR-T cell therapy research, Immunotherapy and Immune Responses, Chronic Myeloid Leukemia Treatments, Virus-based gene therapy research, Viral Infectious Diseases and Gene Expression in Insects
Most-Cited Works
- → Regulation of myeloid leukaemia by the cell-fate determinant Musashi(2010)365 cited
- → Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer(2016)227 cited
- → Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma(2016)145 cited
- → A novel antibody-TCR (AbTCR) platform combines Fab-based antigen recognition with gamma/delta-TCR signaling to facilitate T-cell cytotoxicity with low cytokine release(2018)119 cited
- → Lis1 regulates asymmetric division in hematopoietic stem cells and in leukemia(2014)113 cited
- → Pharmacological rescue of diabetic skeletal stem cell niches(2017)104 cited
- → Control of inflammation by stromal Hedgehog pathway activation restrains colitis(2016)89 cited
- → Fearful Symmetry: Subversion of Asymmetric Division in Cancer Development and Progression(2015)59 cited
- → High-resolution imaging and computational analysis of haematopoietic cell dynamics in vivo(2016)33 cited
- → A stem cell reporter based platform to identify and target drug resistant stem cells in myeloid leukemia(2020)16 cited